Related Experiment Video
Updated: Aug 26, 2026

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
Renal replacement therapy neutralizes elevated MIF levels in septic shock
Julia Pohl1, Maria Papathanasiou1, Martin Heisler1
1West-German Heart and Vascular Center Essen, Department of Cardiology and Department ofVascular Medicine, University Hospital Essen, Hufelandstr. 55, 45147 Essen, Germany.
Background:
Macrophage migration inhibitory factor (MIF) is known to amplify the immune response in septic animal models. Few clinical data support this pro-inflammatory role in septic patients. Renal replacement therapy (RRT) as adjuvants in the complex therapy of sepsis has been proposed as a possible approach to eliminate elevated circulating cytokines. Since recent data suggest that MIF can be effectively removed from the circulating blood pool in patients with chronic kidney disease, we here aimed to investigate whether RRT in septic shock can lower plasma levels of this pro-inflammatory cytokine in septic shock patients.
Methods:
An observational single-center study on an internist intensive care unit (ICU) was conducted. MIF plasma levels and mortality of n = 25 patients with septic shock were assessed with a previously validated method for reliable MIF values. The effect of continuous renal replacement therapy (CRRT) on daily MIF levels and mortality was assessed by comparing patients with and without need for CRRT due to acute kidney injury (AKI).
Results:
MIF plasma levels in patients undergoing CRRT due to septic AKI were steadily decreased compared to those from patients without CRRT hinting at a MIF removal by hemodialysis. MIF release during ICU stay as assessed by MIFAUC was lower in patients undergoing CRRT, and Kaplan-Meier analysis revealed a distinctly lower mortality in patients undergoing CRRT. Analysis of daily MIF levels showed that patients who did not survive septic shock exhibited steadily higher MIF plasma levels and higher MIFAUC compared to those surviving sepsis. Low MIF levels were closely associated with improved survival.
Conclusions:
This is the first study investigating the effect of efficient MIF removal from the plasma pool of patients with septic shock. Reduction of high circulating MIF by CRRT therapy was accompanied by improved survival. Thus, targeted removal of MIF from the circulating blood pool might be a promising approach to reduce mortality in severe sepsis.
Insights
Continuous renal replacement therapy (CRRT) effectively reduced macrophage migration inhibitory factor (MIF) levels in septic shock patients. Lowering MIF through CRRT correlated with improved survival rates, suggesting a potential therapeutic strategy for severe sepsis.
Area of Science:
- Critical Care Medicine
- Immunology
- Nephrology
Background:
- Macrophage migration inhibitory factor (MIF) amplifies immune responses in sepsis, but clinical data on its role in septic patients are limited.
- Renal replacement therapy (RRT) is explored for cytokine removal in sepsis.
- MIF removal by RRT in chronic kidney disease suggests potential for septic shock patients.
Purpose of the Study:
- To investigate if RRT can lower plasma levels of the pro-inflammatory cytokine MIF in septic shock patients.
- To assess the impact of continuous RRT (CRRT) on MIF levels and mortality in septic shock with acute kidney injury (AKI).
Main Methods:
- Observational, single-center study in an ICU involving 25 septic shock patients.
- Assessed plasma MIF levels and mortality using a validated method.
- Compared MIF levels and mortality between patients with and without CRRT for septic AKI.
Main Results:
- CRRT significantly decreased plasma MIF levels in septic shock patients with AKI, indicating MIF removal by hemodialysis.
- Patients undergoing CRRT showed lower MIF release (MIFAUC) and distinctly lower mortality.
- Higher MIF levels and MIFAUC were associated with non-survival in septic shock.
Conclusions:
- This study demonstrates efficient MIF removal from plasma in septic shock patients via CRRT.
- Reduction of circulating MIF by CRRT correlated with improved survival.
- Targeted MIF removal may be a promising therapeutic strategy to reduce mortality in severe sepsis.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

